Open offer detailed public statement filed for Bliss GVS Pharma
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.2 pts more than Nifty Microcap 250 and 8.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Manager SBI Capital Markets has filed a Detailed Public Statement with NSE for an open offer to public shareholders of Bliss GVS Pharma under SEBI Takeover Regulations 2011. Filing made under regulations covering substantial acquisition of shares. The detailed statement will contain offer price, share quantity, and timeline. Public shareholders should review the offer document for exit opportunity.
Shareholders can review the detailed public statement for offer price and tendering details. May create short-term price volatility.